Article By:
Rod Raynovich
Friday, November 12, 2021 2:12 PM EDT
Today JNJ announced a split of the Company separating its legacy consumer products from higher growth growing biopharmaceutical and medtech products.
Celgene Corporation Offers Compelling Growth Opportunity: Wedgewood
Thanks 63 hedge funds invest in $CELG, 12 phase III programs and $100 Billion in free cash flow over the next 10 years! Stellar!